BioMelbourne Network
Progressing BioIndustry
News and Opinions
2012
October
The Search is on for the Next Big Innovation:Springboarding the Growth of Entrepreneurial Ventures Led by Women
Sydney, Australia–11 October, 2012–The search is on for Australia’s most promising women-led growth companies to join a highly successful global business accelerator program, Springboard Enterprises.
The 500+ companies that have participated since 2000 raised over $5.5 billion and created some of USA’s most innovative and disruptive technologies. Australian applications open for the first time... read more…
Major Global Deal For Australian Biotech Start-Up
October 9 2012 The Minister for Industry and Innovation, Greg Combet, today congratulated Australian biotechnology start-up, Vaxxas, on a research collaboration with major US pharmaceutical company Merck. “This collaboration reflects the potential significance of Vaxxas’ Nanopatch – it may one day change the way vaccinations are administered,” Mr Combet said. “The deal is further evidence of th... read more…
Update On Fondaparinux - First Profits
October 4 2012. Alchemia Limited, Brisbane, Australia (ASX:ACL), announces an update on its marketed product, generic fondaparinux, which was launched in the United States in July 2011 by its worldwide marketing partner Dr Reddy’s Laboratories, Inc (DRL). Alchemia is pleased to announce that it expects to receive its first profit arising from sales of fondaparinux in the US for the quarter... read more…
BREVAGen™ Cleared for Sale into Florida
October 4 2012. Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) is pleased to announce that BREVAGen™ has been cleared for sale into the State of Florida following the grant of a permit to the Company’s Australian-based laboratory by the Clinical Laboratory Unit of the Florida Agency for Healthcare Administration (“AHCA”).This news follows the Company’s July 2012 market update annou... read more…
September
The Florey Institute of Neuroscience and Mental Health and Servier Collaborate on Novel Target for Alzheimer's
SURESNES, France and MELBOURNE, Australia 28th September, 2012. Les Laboratoires Servier, a leading European pharmaceutical company and the Florey Institute of Neuroscience and Mental Health together with its collaborative partners, St Vincent’s Institute of Medical Research and Monash University, today announced a collaborative agreement over the role of Insulin-Regulated AminoPeptidase (IRAP)... read more…
CSL Drug Candidate in Diabetes Research Breakthrough
Melbourne, Australia — 27/09/2012
CSL Limited has developed a new drug candidate that is able to prevent the development of type 2 diabetes and reverse its progression in animal models of the disease. The drug candidate blocks signalling by a protein known as Vascular Endothelial Growth Factor B (VEGF-B) and this prevents fat from accumulating in the “wrong” places, such as in muscles an... read more…
Allied’s CardioCel® authorised for early use in patients
26th September, 2012 - Allied’s CardioCel® authorised for early use in patients- TGA gives authorisation to CardioCel® tissue patch under Authorised Prescriber Scheme- CardioCel® continues to gain support of key cardiothoracic surgeons- Additional authorisations expected in the near futureAllied Healthcare Group (ASX: AHZ) announced today the Therapeutic Goods Administration (TGA) has authoris... read more…
Bionomics Key Additions to Executive Team
September 13 2012. Bionomics Limited (ASX: BNO, ADR: BMICY) has made three appointments to its executive team. Dr José Iglesias joins Bionomics as Chief Medical Officer (CMO) and Dr Jeremy Simpson as Vice President of Clinical Development, while BNC210 project leader Dr Sue O’Connor has been promoted to Vice President of Neuroscience Research.Dr Iglesias will commence employment on November 1s... read more…
Coalition's $5 million business innovation program
Thursday 13 September 2012
Coalition’s $5 million business innovation program
The Victorian Coalition Government is making it simpler for businesses to gain access to advice that will enable them to improve their productivity through innovation.
Minister for Innovation, Services and Small Business Louise Asher today announced details of the new $5 million Innovation Voucher Program ... read more…
Starpharma Signs Cancer Drug Agreement with AstraZeneca
September 6 2012. Starpharma Holdings Ltd (ASX:SPL;OTCQX:SPHRY) today announced the signing of an agreement with global pharmaceutical company AstraZeneca giving AstraZeneca the right to test certain proprietary Starpharma oncology molecules based on Starpharma’s dendrimer technology.Under the agreement AstraZeneca will undertake oncology studies using specific Starpharma drug-dendrime... read more…
